Source:http://linkedlifedata.com/resource/pubmed/id/16971669
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2006-12-7
|
pubmed:abstractText |
The deleted in colorectal cancer (DCC) protein, the product of DCC tumor suppressor gene, is frequently altered in cancer. Preclinical data demonstrate that DCC regulates beta-catenin levels. Here, we sought to determine the association of DCC with beta-catenin protein levels, clinicopathological parameters and patient outcome in ovarian cancer using a method of in situ compartmentalized protein analysis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0923-7534
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1797-802
|
pubmed:meshHeading |
pubmed-meshheading:16971669-Automation,
pubmed-meshheading:16971669-Cohort Studies,
pubmed-meshheading:16971669-Female,
pubmed-meshheading:16971669-Fluorescent Antibody Technique,
pubmed-meshheading:16971669-Genes, DCC,
pubmed-meshheading:16971669-Humans,
pubmed-meshheading:16971669-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:16971669-Ovarian Neoplasms,
pubmed-meshheading:16971669-Survival Analysis,
pubmed-meshheading:16971669-Tissue Array Analysis,
pubmed-meshheading:16971669-beta Catenin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancer.
|
pubmed:affiliation |
Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece. abamias@med.uca.gr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|